Discover

PALI
Palisade Bio, Inc.
1.59
2 x 1.21
2 x 2.03
bid
ask
-
0.11
6.47%
2 @ 07:42 PM
1.61 +0.02 (1.13%)
Ytd-32.34%
1y165.00%
1.58
day range
1.72
0.60
52 week range
2.80
Open1.68Prev Close1.70Low1.58High1.72Mkt Cap277.09M
Vol6.87MAvg Vol2.97MEPS0.65P/E2.45Forward P/E-0.19
Beta1.33Short Ratio0.29Inst. Own3.58%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1550-d Avg2.01200-d Avg1.941yr Est30.33
Income Statement
Total Revenue500.00K
Revenues (USD)500.00K
Gross Profit500.00K
Operating Expenses12.20M
Research and Development Expense7.40M
Selling, General and Administrative Expense4.80M
Operating Income-11.70M
Net Income-10.57M
Net Income Common Stock-10.57M
Net Income Common Stock (USD)-10.57M
Consolidated Income-10.57M
Earnings per Basic Share-0.05
Earnings per Basic Share (USD)-0.05
Earnings per Diluted Share-0.05
Earning Before Interest & Taxes (EBIT)-10.57M
Earning Before Interest & Taxes (USD)-10.57M
Weighted Average Shares211.38M
Weighted Average Shares Diluted211.38M
Balance Sheet
Cash and Equivalents125.23M
Cash and Equivalents (USD)125.23M
Trade and Non-Trade Receivables500.00K
Current Assets127.26M
Total Assets127.32M
Current Liabilities5.25M
Total Liabilities5.57M
Accumulated Retained Earnings (Deficit)-172.90M
Shareholders Equity121.75M
Shareholders Equity (USD)121.75M
Assets Non-Current55.00K
Liabilities Non-Current321.00K
Trade and Non-Trade Payables1.84M
Cash Flow
Net Cash Flow from Financing147.00K
Net Cash Flow / Change in Cash & Cash Equivalents-7.46M
Issuance (Purchase) of Equity Shares147.00K
Net Cash Flow from Operations-7.60M
Share Based Compensation4.79M